It is possible that calcimimetics also mitigate the increases in macrophage TNFα, thereby attenuating the cytokine storm associated with COVID-19 [53], or preventing an impaired neutrophil activation to mount an appropriate anti-viral response [54]. Here, TNF is linked to COVID-19.